BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23755200)

  • 1. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.
    Mez J; Cosentino S; Brickman AM; Huey ED; Manly JJ; Mayeux R
    PLoS One; 2013; 8(6):e65246. PubMed ID: 23755200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.
    Mez J; Cosentino S; Brickman AM; Huey ED; Manly JJ; Mayeux R
    Alzheimer Dis Assoc Disord; 2013; 27(3):218-25. PubMed ID: 23954887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different demographic, genetic, and longitudinal traits in language versus memory Alzheimer's subgroups.
    Mez J; Cosentino S; Brickman AM; Huey ED; Mayeux R
    J Alzheimers Dis; 2013; 37(1):137-46. PubMed ID: 23788008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.
    Dickerson BC; Wolk DA;
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):45-51. PubMed ID: 20562467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias.
    Pillai JA; Bena J; Maly EF; Leverenz JB
    Alzheimers Dement; 2023 Jul; 19(7):2956-2965. PubMed ID: 36648159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Delano-Wood L; Bondi MW
    J Int Neuropsychol Soc; 2017 Jul; 23(6):521-527. PubMed ID: 28487004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.
    Pillai JA; Bonner-Jackson A; Walker E; Mourany L; Cummings JL
    Dement Geriatr Cogn Disord; 2014; 38(3-4):224-33. PubMed ID: 24903099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological Similarities and Differences Between Amnestic Alzheimer's Disease and its Non-Amnestic Variants.
    Mendez MF; Monserratt LH; Liang LJ; Chavez D; Jimenez EE; Maurer JJ; Laffey M
    J Alzheimers Dis; 2019; 69(3):849-855. PubMed ID: 31156165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
    Risacher SL; Anderson WH; Charil A; Castelluccio PF; Shcherbinin S; Saykin AJ; Schwarz AJ;
    Neurology; 2017 Nov; 89(21):2176-2186. PubMed ID: 29070667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    Scheltens NME; Tijms BM; Heymans MW; Rabinovici GD; Cohn-Sheehy BI; Miller BL; Kramer JH; Wolfsgruber S; Wagner M; Kornhuber J; Peters O; Scheltens P; van der Flier WM;
    J Alzheimers Dis; 2018; 65(3):1029-1039. PubMed ID: 30103316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
    J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
    J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysis.
    Libon DJ; Drabick DA; Giovannetti T; Price CC; Bondi MW; Eppig J; Devlin K; Nieves C; Lamar M; Delano-Wood L; Nation DA; Brennan L; Au R; Swenson R
    J Alzheimers Dis; 2014; 42(3):999-1014. PubMed ID: 25024329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum.
    Ranasinghe KG; Hinkley LB; Beagle AJ; Mizuiri D; Dowling AF; Honma SM; Finucane MM; Scherling C; Miller BL; Nagarajan SS; Vossel KA
    Neuroimage Clin; 2014; 5():385-95. PubMed ID: 25180158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.